PRTN3 and atherosclerosis: Importantly, the chronic inflammation associated with increased stability of pathogenic ACPA-IgG might also contribute to the extra-articular involvement in RA patients, including cardiovascular comorbidities such as impaired cardiac function, accelerated atherosclerosis and endothelial dysfunction (55, 56).